Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Ireland Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20131
20141
20151
20181
20191
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eidos Therapeutics, a BridgeBio company2
Eisai Inc.1
H. Lundbeck A/S1
Novo Nordisk A/S1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Prof Brian Lawlor1
Renew Research, LLC1
vTv Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease9
Amyloid Neuropathies, Familial2
Amyloidosis2
Cardiomyopathies2
Heart Diseases2
Cognitive Dysfunction1
Dementia1
Memory Disorders1
Pain1
Polyneuropathies1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.